Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

554
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

996
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
996
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing Infections in Children after Out-of-Hospital Cardiac Arrest.

Resuscitation·2026
Same author

Comparative decision-making analysis of extracorporeal membrane oxygenation candidacy based on a survey of pediatric critical care fellow and attending physicians☆.

The journal of extra-corporeal technology·2026
Same author

Association of Extubation Timing and Treatment Failure After Successful Extubation Readiness Trial in Pediatric Patients.

Respiratory care·2026
Same author

The Impact of Variable Arterial Catheter Flushing Practices on Flow Rates and Infusion Pressures.

Anesthesia and analgesia·2026
Same author

Extracorporeal cardiopulmonary resuscitation for pediatric cardiac arrest: lifesaving rescue, but not for everyone.

Current opinion in pediatrics·2026
Same author

Revised Recommendations for Restarting Teclistamab Following Dose Delays: Insights from the MajesTEC-1 Study on Clinical Safety, and from Simulated Pharmacokinetics and Cytokine Dynamics.

Targeted oncology·2026

Related Experiment Video

Updated: May 3, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

30.6K

Methods for pharmacokinetic analysis in young children.

Adam S Himebauch1, Athena Zuppa

  • 1The Children's Hospital of Philadelphia, Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine , Main Building, Suite 7C26, 34th Street and Civic Center Blvd, Philadelphia, PA 19104 , USA zuppa@email.chop.edu.

Expert Opinion on Drug Metabolism & Toxicology
|February 13, 2014
PubMed
Summary

Optimizing pediatric drug dosing requires advanced clinical trial design and analysis. Innovative pharmacokinetic (PK) modeling and simulation techniques are crucial for individualized pediatric pharmacotherapy.

More Related Videos

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

7.3K
A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

14.1K

Related Experiment Videos

Last Updated: May 3, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

30.6K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

7.3K
A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

14.1K

Area of Science:

  • Pediatric Clinical Pharmacology
  • Drug Development
  • Pharmacokinetics

Background:

  • Pediatric physiology and disease states differ significantly from adults.
  • There's a growing need to optimize clinical pharmacology study design for pediatric populations.
  • Ensuring appropriate drug-dosing practices for children is a key concern for clinicians, scientists, and regulators.

Purpose of the Study:

  • To review innovative techniques for pediatric clinical trial design and analysis.
  • To highlight advancements in pharmacokinetic (PK) studies, including sample preparation and data analysis.
  • To discuss the application of PK modeling and simulation in pediatric pharmacology.

Main Methods:

  • Review of innovative techniques in sample preparation and analysis for PK studies.
  • Exploration of modern data analysis methods, including PK modeling and simulation.
  • Examination of recent literature examples demonstrating these methods in pediatric populations.

Main Results:

  • Significant challenges exist in pediatric clinical trial design, implementation, and analysis.
  • Innovative PK techniques and data analysis methods offer solutions to these challenges.
  • Advances in clinical trial design, sample analysis, and PK/pharmacodynamic modeling are evident.

Conclusions:

  • Further progress in pediatric clinical pharmacology necessitates interdisciplinary collaboration.
  • Individualized dosing for pediatric patients is an achievable goal.
  • New methods and algorithms developed for pediatric pharmacotherapy can benefit broader drug development.